Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 1,579 | 2,559 | 3,315 | 1,737 | 2,177 |
| Operating Income | -1,579 | -2,559 | -3,315 | -1,737 | -2,177 |
| Interest Expense | 604 | 725 | 546 | 405 | 136 |
| Other Income | 81 | 139 | -440 | 26 | -279 |
| Pre-tax Income | -2,103 | -3,145 | -4,301 | -2,115 | -2,592 |
| Net Income Continuous | -2,103 | -3,145 | -4,301 | -2,115 | -2,592 |
| Net Income | $-2,103 | $-3,145 | $-4,301 | $-2,115 | $-2,592 |
| EPS Basic Total Ops | -0.04 | -0.04 | -0.22 | -5.41 | -7.70 |
| EPS Basic Continuous Ops | -0.02 | -0.04 | -0.17 | -5.41 | -7.73 |
| EPS Diluted Total Ops | -0.04 | -0.04 | -0.22 | -5.41 | -7.70 |
| EPS Diluted Continuous Ops | -0.02 | -0.04 | -0.17 | -5.41 | -7.73 |
| EPS Diluted Before Non-Recurring Items | -0.04 | N/A | -0.22 | -5.40 | -7.70 |
| EBITDA(a) | $-1,188 | $-2,006 | $-2,941 | $-1,521 | $-2,168 |